Dr. Mubarak Naqvi heads the Clinical Study Unit at SANOFI in India. His team is involved in phase II to IV clinical trials, post marketing studies, registries and bio-equivalence studies; and covers the whole spectrum of activities – from protocol development to CSR. The team also works closely with their Medical Affairs colleagues in developing pre and post approval strategies for SANOFI’s drugs, including the life cycle management and access programs.
Dr. Naqvi is a physician with post graduate training in oncology and clinical biochemistry. He is passionate about clinical project management, and likes to develop, refine and implement the classic project management principles for successful conduct of clinical trials. He frequently speaks and conducts workshops on the same subject.
Before joining SANOFI, Dr. Naqvi worked at different positions with a US based SMO/CRO. Besides managing the Oncology division in the US, he was instrumental in establishing the Indian operations for this company. After seven interesting years of working in geographies like Fargo, North Dakota; Orange County, California; Princeton, New Jersey and New Delhi, India; he moved to another organization: this time it was an Indian CRO that later established its presence in the US and UK; and successfully ran global projects across several geographies in Asia, Europe and the US.
Having worked in the SMO and the CRO settings, Dr. Naqvi decided to work on the pharma side and joined SANOFI in early 2010 where he continues to enjoy the exciting world of clinical development. In addition, he also works closely with some of his colleagues in early R&D - where the focus is on studying disease patterns in the Asia-Pacific region to find specific cures for some of the most challenging diseases that are prevalent in this area.
Dr. Naqvi has been a DIA volunteer for about 6 years and serves the Regional Advisory Council (RAC) of the DIA’s Indian Chapter